Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Evaluation of susceptibility of Mycobacterium bovis to antituberculous drugs by radiometric BACTEC 460TB system.

Cavirani S, Fanti F, Benecchi M, Calderaro A, Taddei S, Arcangeletti C, Medici MC, Dettori G, Chezzi C.

New Microbiol. 2003 Apr;26(2):181-6.

PMID:
12737201
2.

Antituberculous drug susceptibility testing of Mycobacterium bovis BCG strain Montréal.

Rousseau P, Dupuis M.

Can J Microbiol. 1990 Oct;36(10):735-7.

PMID:
2253115
3.

GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples.

Lacoma A, Garcia-Sierra N, Prat C, Ruiz-Manzano J, Haba L, Rosés S, Maldonado J, Domínguez J.

J Clin Microbiol. 2008 Nov;46(11):3660-7. doi: 10.1128/JCM.00618-08. Epub 2008 Sep 10.

4.

Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis.

Garrigó M, Aragón LM, Alcaide F, Borrell S, Cardeñosa E, Galán JJ, Gonzalez-Martín J, Martin-Casabona N, Moreno C, Salvado M, Coll P.

J Clin Microbiol. 2007 Jun;45(6):1766-70. Epub 2007 Apr 18.

5.
6.

Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.

Akselband Y, Cabral C, Shapiro DS, McGrath P.

J Microbiol Methods. 2005 Aug;62(2):181-97. Epub 2005 Mar 29.

PMID:
16009276
7.

Molecular basis of rifampin and isoniazid resistance in Mycobacterium bovis strains isolated in Sardinia, Italy.

Sechi LA, Zanetti S, Sanguinetti M, Molicotti P, Romano L, Leori G, Delogu G, Boccia S, La Sorda M, Fadda G.

Antimicrob Agents Chemother. 2001 Jun;45(6):1645-8.

8.

Synergistic activities of clarithromycin and antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis.

Cavalieri SJ, Biehle JR, Sanders WE Jr.

Antimicrob Agents Chemother. 1995 Jul;39(7):1542-5.

10.
11.

Multicenter evaluation of ethambutol susceptibility testing of mycobacterium tuberculosis by agar proportion and radiometric methods.

Madison B, Robinson-Dunn B, George I, Gross W, Lipman H, Metchock B, Sloutsky A, Washabaugh G, Mazurek G, Ridderhof J.

J Clin Microbiol. 2002 Nov;40(11):3976-9.

13.
14.

Comparison of Mycobacterium tuberculosis susceptibility testing performed with BACTEC 460TB (Becton Dickinson) and MB/BacT (Organon Teknika) systems.

Tortoli E, Mattei R, Savarino A, Bartolini L, Beer J.

Diagn Microbiol Infect Dis. 2000 Oct;38(2):83-6.

PMID:
11035238
15.

Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy.

Johansen IS, Thomsen VØ, Marjamäki M, Sosnovskaja A, Lundgren B.

Diagn Microbiol Infect Dis. 2004 Oct;50(2):103-7.

PMID:
15474318
17.

Evaluation of the BacT/ALERT PZA kit in comparison with the BACTEC 460TB PZA for testing Mycobacterium tuberculosis susceptibility to pyrazinamide.

Aragón LM, Garrigó M, Moreno C, Español M, Coll P.

J Antimicrob Chemother. 2007 Sep;60(3):655-7. Epub 2007 Jul 5.

PMID:
17615155
18.

Comparison of the in vitro activities of rifapentine and rifampicin against Mycobacterium tuberculosis complex.

Bemer-Melchior P, Bryskier A, Drugeon HB.

J Antimicrob Chemother. 2000 Oct;46(4):571-6.

PMID:
11020254
19.

Supplemental Content

Support Center